OpenMed-NER-BloodCancerDetect-BioPatient-108M EU AI Act Compliance Profile
OpenMed
Your risk depends on how you use OpenMed-NER-BloodCancerDetect-BioPatient-108M
| Usage Context | Risk Level | Obligations |
|---|---|---|
| Internal coding tool | MINIMAL | 3 obligations (~12h) |
| Customer support bot | LIMITED | 7 obligations (~32h) |
| HR screening / hiring | HIGH | 19 obligations (~120h) |
| Credit decisions | HIGH | 19 obligations (~120h) |
| Medical triage | HIGH | 19 obligations (~120h) |
Why this tool is classified as HIGH RISK
OpenMed-NER-BloodCancerDetect-BioPatient-108M is a token classification model by OpenMed. Built with transformers. Supports en. Licensed under apache-2.0. 84.9K downloads on HuggingFace.
Applicable Articles
Who does what
OpenMed (provider)Their job
- Provider obligations being compiled
You (deployer)Your job
- •AI Literacy (Art. 4) (Art. 4)
- •AI Disclosure (Art. 50) (Art. 50)
- •Human Oversight (Art. 26) (Art. 26)
- •Data Governance (Art. 10) (Art. 10)
- •Robustness Monitoring (Art. 26) (Art. 26)
Risk Assessment Reasoning
The AI tool is designed for medical applications, specifically for detecting blood cancer, which poses significant risks to health and safety if misused or if it provides inaccurate results. Therefore, it falls under the high-risk category of the EU AI Act.
More models by OpenMed
Similar Token Classification models
Frequently Asked Questions
What is OpenMed-NER-BloodCancerDetect-BioPatient-108M's EU AI Act risk classification?
+
OpenMed-NER-BloodCancerDetect-BioPatient-108M is classified as HIGH RISK under the EU AI Act. This means 7 mandatory obligations including conformity assessment, FRIA, and human oversight requirements. The model has 108M parameters.
What are my obligations if I deploy OpenMed-NER-BloodCancerDetect-BioPatient-108M?
+
As a OpenMed-NER-BloodCancerDetect-BioPatient-108M deployer, you have 7 base obligations (~96 hours estimated effort). Key articles: Art. 4, Art. 50, Art. 26, Art. 10.
What is OpenMed-NER-BloodCancerDetect-BioPatient-108M?
+
OpenMed-NER-BloodCancerDetect-BioPatient-108M is a Token Classification model by OpenMed. It has 84.9K downloads on HuggingFace. Licensed under apache-2.0.
What are the EU AI Act deadlines for OpenMed-NER-BloodCancerDetect-BioPatient-108M?
+
Already passed: AI Literacy (Art. 4) — 2025-02-02. Already passed: AI Disclosure (Art. 50) — 2025-08-02. Upcoming: Human Oversight (Art. 26) — 2027-08-02. Upcoming: Data Governance (Art. 10) — 2027-08-02. Upcoming: Robustness Monitoring (Art. 26) — 2027-08-02. Upcoming: FRIA (Art. 27) — 2027-08-02. Upcoming: Risk Management (Art. 9) — 2027-08-02.
Check OpenMed-NER-BloodCancerDetect-BioPatient-108M compliance in your codebase
One command to scan. Open-source CLI.